Journals / Türk Pediatri Arşivi / 2017 / Cilt: 52 - Sayı: 3

Role of genetics in pediatric rheumatology

Çocuk romatolojisinde genetiğin yeri

Pages
113–121
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we discuss the three groups of autoinflammatory diseases and role of genetics in their diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pediatric rheumatology includes autoinflammatory monogenic diseases, autoinflammatory multifactorial diseases with complex inheritance, and diseases with uncertain clinical diagnosis or undefined conditions, even though they show signs of autoinflammation.
📊
Key Findings & Data:It is possible to identify disease genes and novel diseases, and lead to new treatment options by gene mapping studies and high-throughput screening strategies for multifactorial diseases and conditions with uncertain clinical characteristics.
💡
Conclusion & Impact:In this review, we discuss the three groups of autoinflammatory diseases and role of genetics in their diagnosis.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pediatric rheumatology includes autoinflammatory monogenic diseases, autoinflammatory multifactorial diseases with complex inheritance, and diseases with uncertain clinical diagnosis or undefined conditions, even though they show signs of autoinflammation. Most of these diseases are systemic; it is important to diagnose patients promptly and definitively and to select proper treatment options based on the diagnoses. Clinical observation and acute-phase responses are usually sufficient for diagnosis; however, genetic analyses can provide supportive data for definite diagnosis and treatment, especially for rare monogenic diseases. As for multifactorial autoinflammatory diseases, susceptibility genes, and factors involved in the etiopathogenesis have not been fully identified. It is possible to identify disease genes and novel diseases, and lead to new treatment options by gene mapping studies and high-throughput screening strategies for multifactorial diseases and conditions with uncertain clinical characteristics. In this review, we discuss the three groups of autoinflammatory diseases and role of genetics in their diagnosis.

Özet

Çocuk romatolojisinde; otoenflamatuar tek gen hastalıkları, karmaşıktip model ile kalıtılan çok etkenli otoenflamatuar hastalıklar ve otoenflamatuar bulguları olmasına rağmen klinik tanısı net konulamayan ya da daha önce tanımlanmamış hastalıklar yer almaktadır. Birçoğu sistemik olan bu hastalıkların hızlı ve kesin tanılarının konulması ve tanıya bağlı olarak doğru tedavilerin seçilmesi önem taşımaktadır. Tanı, genellikle klinik gözlem ve akut faz yanıtlarının incelenmesi ile konabilmektedir, fakat özellikle nadir tek gen hastalıkları için genetik analiz sonuçları kesin tanıyı destekleyici ya da tedaviye yön verici olabilmektedir. Çok etkenli otoenflamatuar hastalıkların ise yatkınlık genleri ve etiyopatogenezlerinde rol oynayan etmenler henüz tümüyle bilinmemektedir. Çok etkenli ve kliniği net olmayan otoenflamatuar hastalık gruplarında hastalık geni arama çalışmalarıyla hastalıktan sorumlu genler ve yeni hastalıklar tanımlanarak tanı ve tedavi yollarının açılması mümkündür. Bu derlemede, bahsedilen üç tipteki otoenflamatuar hastalık grubu ve genetik çalışmaların bu hastalıkların tanısındaki önemi anlatılmaktadır.

🔖

Cite This Article

KASAPÇOPUR, Ö., AYDIN, A. K., EVEREST, E., BALAMİR, A., TURANLI, E. T. (2022). Role of genetics in pediatric rheumatology. Türk Pediatri Arşivi, Cilt: 52 - Sayı: 3, 113–121. https://ajindex.com/articles/641074

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Caso F, Rigante D, Vitale A, et al. Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol 2013
  2. 513782. [CrossRef ] 2. Rigante D, Vitale A, Lucherini OM, Cantarini L. The hereditary autoinflammatory disorders uncovered. Autoimmun Rev 2014
  3. [CrossRef ] 3. Bidari A, Ghavidel-Parsa B, Najmabadi H, et al. Common MEFV mutation analysis in 36 Iranian patients with familial Mediterranean fever: clinical and demographic significance. Mod Rheumatol 2010
  4. [CrossRef ] 4. Delague V, Kriegshäuser G, Oberkanins C, Mégarbané A. Reverse-hybridization vs. DNA sequencing in the molecular diagnosis of familial Mediterranean fever. Genet Test 2004
  5. [CrossRef ] 5. van Dijk EL, Auger H, Jaszczyszyn Y, Thermes C. Ten years of next-generation sequencing technology. Trends Genet 2014
  6. [CrossRef ] 6. Zhang W, Cui H, Wong LJ. Application of next generation sequencing to molecular diagnosis of inherited diseases. Top Curr Chem 2014
  7. [CrossRef ] 7. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997
  8. [CrossRef ] 8. Chae JJ, Aksentijevich I, Kastner DL. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 2009
  9. [CrossRef ] 9. Infevers. The registry of hereditary auto-inflammatory disorders mutations 2014. address: http://fmf.igh.cnrs.fr/ ISSAID/infevers/ (Date retrieved: 27.04.2015). 10. Ozturk C, Halıcıoglu O, Coker I, et al. Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey. Clin Rheumatol 2012
  10. [CrossRef ] 11. Touitou I, Sarkisian T, Medlej-Hashim M, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 2007
  11. [CrossRef ] 12. Akpolat T, Özkaya O, Özen S. Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients. Gene 2012
  12. [CrossRef ] 13. Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BH, Toghill PJ. Familial hibernian fever. Q J Med 1982
  13. Rebelo SL, Bainbridge SE, Amel-Kashipaz MR, et al. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptorassociated periodic syndrome indicates